MRI may sharpen radiation aim in esophageal cancer

NCT ID NCT07416825

Completed Knowledge-focused Sponsor: Institute of Oncology Ljubljana Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether using MRI scans can reduce differences in how doctors outline esophageal cancer tumors for radiation therapy. Twenty-three patients with advanced esophageal cancer had MRI scans in addition to standard CT and PET/CT scans. Five radiation oncologists independently drew tumor boundaries on each type of scan, and researchers measured how much their outlines varied. The goal was to see if MRI leads to more consistent tumor targeting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If MRI improves consistency in tumor targeting, it could lead to more precise radiotherapy planning for esophageal cancer.
What could go wrong: This is a small, completed imaging study with only 23 patients, so results may not apply widely. It does not test treatment outcomes or patient survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma of esophagus esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL CANCER ESOPHAGEAL CARCINOMA

Contacts and locations

Locations

Institute of Oncology Ljubljana

Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.